Study of Cosibelimab in Subjects With Relapsed or Refractory Lymphoma

Clinical trial NCT03778073 · TERMINATED

Trial details

NCT number: NCT03778073
Sponsor: TG Therapeutics, Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

B-cell Non Hodgkin Lymphoma Richter's Transformation

Start date: 2019-04-17
Primary completion: 2022-05-03
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.